Product Images Natpara (parathyroid Hormone)
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 48 images provide visual information about the product associated with Natpara (parathyroid Hormone) NDC 68875-0204 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - natpara 01
Figure 2 - natpara 02
This is a graph showing the concentration of plasma parathyroid hormone (in pg/mL) following treatment with 100 g PTH (1-84). The X-axis represents hours, and the Y-axis shows the concentration of the hormone. The lower limit of quantification for parathyroid hormone is 10.0 pg/mL. Additionally, the graph also shows albumin-corrected serum total calcium (in mg/dL) levels obtained after treatment with 100 g thPTH (1-84).*
Cartridge Tracker - natpara 03
This appears to be labeling information related to cartridges and their expiration dates. The two cartridges (labeled "Cartridge 1" and "Cartridge 2") have been mixed on a certain date, and each cartridge has a specific "discard on" date. It seems that cartridge 1 has no specific date but should be simply discarded when it is used later. Cartridge 2, on the other hand, can be used until two weeks after the date it was mixed (which is not available from the given text). Overall, this seems to be an inventory management system to ensure that cartridges are used before they expire.*
Figure A - natpara 04
Figure B - natpara 05
Figure C - natpara 06
Figure D - natpara 07
Figure E - natpara 08
Figure F - natpara 09
Figure G - natpara 10
Figure H - natpara 11
Figure I - natpara 12
Figure J - natpara 13
Figure K - natpara 14
Figure L - natpara 15
Figure M - natpara 16
Figure N - natpara 17
Figure O - natpara 18
Figure P - natpara 19
Figure Q - natpara 20
Figure R - natpara 21
Figure S - natpara 22
Figure T - natpara 23
Figure U - natpara 24
Figure V - natpara 25
Figure W - natpara 26
Figure X - natpara 27
Figure Y - natpara 28
Figure Z - natpara 29
Figure AA - natpara 30
Figure BB - natpara 31
Figure CC - natpara 32
Figure DD - natpara 33
Figure EE - natpara 34
Figure FF - natpara 35
Figure GG - natpara 36
Figure HH - natpara 37
Figure II - natpara 38
Figure JJ - natpara 39
Figure - natpara 40
Figure KK - natpara 41
Figure LL - natpara 42
Figure MM - natpara 43
Figure NN - natpara 44
PRINCIPAL DISPLAY PANEL - 25 mcg Cartridge Carton - natpara 45
This is a description of a medication called Natpara. It is a subcutaneously administered injection used for the treatment of parathyroid hormone deficiency. The medication is packaged in cartridges, each containing 14 doses, and it must be refrigerated. A healthcare provider must administer the drug, and it comes with a mixing device and needles. The medication must be used within 14 days of mixing. The text contains some gibberish, but the description manages to give information on the essential features of the medication.*
PRINCIPAL DISPLAY PANEL - 50 mcg Cartridge Carton - natpara 46
This is a description of a medication that contains parathyroid hormone, Natpara. It is designed for subcutaneous use only and comes in a packaged pen that requires BD Ultra-Fine Pen Needles. It needs to be refrigerated to be stored, and the solution should be discarded after 14 days. There are instructions for use included in this package, with a warning to not freeze and to store at a specific temperature range.*
PRINCIPAL DISPLAY PANEL - 75 mcg Cartridge Carton - natpara 47
PRINCIPAL DISPLAY PANEL - 100 mcg Cartridge Carton - natpara 48
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.